Ylva Haig

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial

Tone Enden, Ylva Haig, Nils‐Einar Kløw et al. · The Lancet · 2011 · 990 citations

Medicine, Surgery, Outcomes Research +9

Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial

Ylva Haig, Tone Enden, Ole Jørgen Grøtta et al. · The Lancet Haematology · 2016 · 445 citations

Medicine, Hematology, Hemostasis +11

Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study

Tone Enden, Hilde Skuterud Wik, Ann Kristin Kvam et al. · BMJ Open · 2013 · 101 citations · Full text

Medicine, Pharmacotherapy, Surgery +17

Determinants of Early and Long-term Efficacy of Catheter-directed Thrombolysis in Proximal Deep Vein Thrombosis

Ylva Haig, Tone Enden, Carl-Erik Slagsvold et al. · Journal of Vascular and Interventional Radiology · 2012 · 94 citations · Full text

Medicine, Internal Medicine, Clinical Pharmacology +13

Long-term Outcome After Additional Catheter-Directed Thrombolysis Versus Standard Treatment for Acute Iliofemoral Deep Vein Thrombosis (the CaVen T Study): A Randomised Controlled Trial

Tone Enden, Ylva Haig · Journal of Vascular Surgery · 2012 · 75 citations

Medicine, Internal Medicine, Outcomes Research +10